1Bartlett JG, Dowell SF, Mandell LA, et al. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis,2000,31:347-382.
2Hauck LD, Adler LM, Mulla ZD. Clinical pathway care improves outcomes among patients hospitalized for community-acquired pneumonia. Ann Epidemiol,2004,14:669-675.
3Lave JR, Lin C J, Hughes CP, et al. The cost of treating patients with community-acquired pneumonia. Semin Respir Crit Care Med, 1999,20:189-197.
6Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med, 1997,336:243-250.
7Meehan TP, Weingarten SR, Holmboe ES, et al. A statewide initiative to improve the care of hospitalized pneumonia patients:The Connecticut Pneumonia Pathway Project. Am J Med, 2001, 111 : 203-210.
8Marrie TJ,Lau CY,Wheeler SL,et al. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA ,2000,283:749-755.
9Carusone SC, Loeb M, Lohfeld L. A clinical pathway for treating pneumonia in the nursing home : part I : the nursing perspective. J Am Med Dir Assoc.2006.7:271-278.
10Carusone SC, Loeb M, Lohfeld L. A clinical pathway for treating pneumonia in the nursing home: part Ⅱ: the administrators' perspective and how it differs from nurses' views. J Am Med Dir Assoc ,2006,7:279-286.
